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Nuclear receptors, such as the retinoic acid receptor (RAR) or the 9-cis retinoic acid receptor
(RXR), interact not only with their ligands but also with other types of receptors and with
DNA. Here, two complementary mass spectrometry (MS) methods were used to study the
interactions between retinoic receptors (RXR/RAR) and DNA: non-denaturing nano-electrospray
(nanoESI MS), and high-mass matrix-assisted laser desorption ionization (MALDI MS)
combined with chemical cross-linking. The RAR·RXR heterodimer was studied in the presence
of a specific DNA sequence (DR5), and a specific RAR·RXR·DNA complex was detected with
both MS techniques. RAR by itself showed no significant homodimerization. A complex
between RAR and the double stranded DR5 was detected with nanoESI. After cross-linking,
high-mass MALDI mass spectra showed that the RAR binds the single stranded DR5, and the
RAR dimer binds both single and double stranded DR5. Moreover, the MALDI mass spectrum
shows a larger RAR dimer signal in the presence of DNA. These results suggest that a
gene-regulatory site on DNA can induce quaternary structural changes in a transcription factor
such as RAR. (J Am Soc Mass Spectrom 2010, 21, 635–645) © 2010 American Society for Mass
Spectrometry
Retinoids (metabolites of vitamin A) exert a widevariety of effects on embryonic development,tissue homeostasis, cell proliferation, differenti-
ation, and apoptosis [1]. Their pleiotropic effects are
mediated through two transcriptional regulators, the
retinoic acid nuclear receptors (RAR, , and  iso-
types), and the retinoid X nuclear receptors (RXR, ,
and  isotypes), which form functional RAR/RXR het-
erodimer. RXR also forms a heterodimer with other
nuclear receptors (NRs) [2, 3] and, in certain cases, can
act on its own or in concert with other signaling
pathways to induce cell differentiation or apoptosis [4].
While RARs are activated by all-trans retinoic acid
(atRA) and 9-cis retinoic acid (RA), RXRs are only
activated by 9-cisRA, although the physiological RXR
ligand remains unknown [5]. Retinoids and rexinoids
(RXR selective) ligands are important drugs for cancer
therapy and prevention, and for metabolic diseases [6].
NRs share a common modular organization with a
variable amino-terminal domain, a conserved DNA-
binding domain (DBD) and the ligand binding domain
(LBD) that represses or activates gene transcription
upon ligand binding and/or cofactor positioning. The
LBD harbors numerous interaction surfaces for multiple
protein partners, including corepressors, coactivators,
and other bridging factors that participate in signal
transduction towards the basal transcriptional machin-
ery. Physiologically, most NRs function as dimers,
resulting in the binding of two DBDs to neighboring
hexanucleotide DNA motifs called hormone response
elements (HREs). Heterodimeric NRs bind to asymmet-
ric response elements with specific polarities that result
from the formation of cooperative interfaces between
DBDs.
All RXR heterodimers preferentially bind DNA on two
sites of a direct repeat (DR) configuration, separated by 1
to 5 nucleic acids, called DR1 to DR5, respectively [3, 7, 8].
It has also been observed that these receptors have higher
affinity and specificity for the DNA as dimers compared
with the monomeric form [7]. Both the binding strength
and the binding selectivity are determined by the rela-
tive orientation, spacing, and nucleotide sequence of the
repeat motifs on DNA [9].
The structure and formation of the RAR.RXR het-
erodimer [3, 10, 11] as well as the homodimer RXR, [3,
12] interacting with DR1 after RA activation have been
previously studied. The structure of this DR1·RAR·RXR
system is well known, however the structure the het-
erodimer with DR5 is still unknown [13]. RXR can bind
to DR1 both as a homodimer and as a heterodimer with
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RAR. As the two direct repeats are separated by only
one base, the two partners are positioned on both sides
of the dsDNA (Figure 1). It has been established that on
DR5, RXR occupies the 5= half-site of the direct repeat of
the double stranded DR5, while RAR occupies the 3=
half-site (Figure 1) [3, 11]. Consequently, they will be
located on the same side of the double strand (Figure 1).
One interesting point, recently observed, is that a bio-
logical response induced by RA activation is present
even in the absence of RXR, which suggests that RAR
could also form a homodimer and interact with DNA
[14]. It has been shown that RXR forms a heterodimer
with various other receptors, but the potential dimer-
ization of all-trans retinoic acid receptors induced by
interaction with a gene-regulatory site has never been
demonstrated.
Here we use a fast and sensitive analytical tool, mass
spectrometry (MS), to determine the interactions be-
tween nuclear receptors and DNA. Since the introduc-
tion of soft ionization methods, MS has become a
valuable technique for characterizing noncovalent com-
plexes. Usually, electrospray ionization (ESI) [15] or
nanoelectrospray (nanoESI) mass spectrometry is pre-
ferred over matrix-assisted laser desorption/ionization
mass spectrometry (MALDI MS) [16, 17] for studying
noncovalent complexes, such as protein–protein, protein–
ligand, protein–DNA, or DNA–DNA complexes. This
is mainly because ESI is able to spray “native-like”
aqueous solutions [18, 19]. However, special sample
preparation procedures such as desalting, and the use
of aqueous volatile solutions at pH7 such as ammo-
nium acetate, are necessary to keep noncovalent com-
plexes intact. Desalting and related purification steps
are not always necessary in the case of MALDI MS due
to its higher salt tolerance. Although noncovalent com-
plexes are easily disrupted in the MALDI process, either
during sample preparation (mixture with acidic organic
matrix) or during desorption/ionization, some studies
have demonstrated the possibility of detecting nonco-
valent protein complexes by MALDI, using specialized
protocols such as desorption/ionization by an IR laser
[20–22], using the first shot analysis [23], or by employ-
ing non-acidic matrices [24].
Recently, the application of MALDI MS has been
extended to the area of large heteromeric noncovalent
complexes by combining chemical cross-linking and
high-mass detection [25–28]. Indeed, an effective strat-
egy to prevent complex dissociation during the MALDI
process is stabilization by chemical cross-linking [29].
Chemical cross-linking is well established and exten-
sively used with proteins, especially for studying inter-
actions, structural effect, or for purification such as
immunoprecipitation [26, 30–33]. Concerning the cross-
linking between proteins and DNA, the efficiency of UV
cross-linking by laser irradiation by the activation of
artificially introduced moieties such as azido groups
has been shown [34–36]. In this fashion, DNA–protein
complexes could be detected and studied by MS [34].
The UV cross-linking mechanism is still not fully
understood [34, 36].
Here, native ESI and high-mass MALDI MS were
used to study the interaction of nuclear receptors with a
specific DNA sequence. ESI, for obtaining accurate
masses and high-mass MALDI, can be combined to obtain
complementary information on noncovalent complexes.
First, we studied the interaction of the RAR·RXR het-
erodimer with DR5. Then, the nuclear receptor RAR
alone was incubated with DNA and studied by both MS
techniques. We also investigated the influence of the
DNA on RAR dimerization.
Experimental
Protein Expression and Purification
Expression of mRXR AB (133-467), mRAR AB (84-
462): for simplification, this will, in the following, be
referred to as RXR and RAR. The nuclear receptors
were expressed in E. coli BL21 (DE3) cells harboring a
pET15b plasmid encoding a N-ter hexahistidine tagged
fusion protein for RAR and a pET31 plasmid encoding
a non-tagged protein for RXR. Cells were grown in LB
Figure 1. Schematic representation of the interaction between RAR, RXR, and DR1 (left) and the
interaction between the heterodimer and DR5 (right). The ligand and DNA binding domains,
schematically represented by a big and a small lobe, respectively, are sketched. The polarity of the
DNA is only specified for the single strand containing the direct repeat.
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medium at 37 °C until the absorbance at 600 nm
reached 0.6–0.8. They were then allowed to grow for
another 3 h at 25 °C after induction with 0.8 mM IPTG.
Cells were harvested by centrifugation and stored at
80 °C until further processing.
Purification: Cell pellets from 2L of His-RAR and
from 2L of His-RAR plus 4L of RXR, respectively, were
mixed and purified first by metal chelating affinity
chromatography (nickel HiTrap crude FF; Pharmacia,
Saint Quentin en Yvelines, France) with elution by
imidazole steps. Protein fractions were then chromato-
graphed on a Superdex S200 26/60 gel-filtration (Phar-
macia) in Tris buffer (20 mM, pH7.5) containing 100
mM NaCl, 100 mM KCl, 5% glycerol, 2 mM Chaps, and
4 mM MgSO4. The ligand, 9-cis retinoic acid (RA) was
then added as a saturated ethanol solution.
One percent of the total sample volume in a 4-fold
molar excess, to saturate the receptors. This did not
cause any detectable aggregation and was enough to
saturate all receptor sites. All subsequent steps were
performed under dimmed light to avoid photolysis
or isomerization of the photosensitive ligand. In the
crystal structure of RAR bound to 9-cis RA, measured
in similar conditions, no isomerization was observed
[37]. 2 mM Tris[2-carboxyethyl] phosphine (TCEP)
was added and the proteins were then concentrated on
Centricon30 (Centricon/Millipore, Molsheim, France)
biological membranes. Purified single-stranded oligo-
nucleotides from Eurogentec (Angers, France) were
annealed in equimolar amounts at 85 °C for 10 min, and
left to cool at 4 °C. The sequence for the DR5 used in this
study is the following: 5=-AGAGGTCAGACAGAGGT-
CAGA-3=/3=-TCTCCAGTCTGTTCCAGTCT-5=, MW 
12,852 Da. The double stranded DNA DR5 contained
the typical binding motif, in bold, (A/G)G(G/T)TCA
separated by five nucleic acids [3]. The purified het-
erodimer RAR·RXR was mixed with a 1.1 molar
excess of DR5 oligonucleotides and dialyzed overnight
at 4 °C against Tris buffer (10 mM, pH7.5) containing 50
mM NaCl, 50 mM KCl, 5% glycerol, 2 mM Chaps, and
4 mM MgSO4. The heterodimeric DNA complex was
further purified by gel-filtration on a Superdex S200
(Superdex/GE Healthcare, Lyon, France) 26/60 station-
ary phase. Fractions containing the RAR·RXR·DR5 com-
plex were pooled and analyzed by native sodium
dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). As the His-tag was not detected during
mass spectrometry measurements, we assume it gets
lost during the purification.
Materials
Disuccinimidyl tartrate, iodoacetic acid N-hydroxysuc-
cinimidyl ester, dithiobis (succinimidyl) propionate,
and octanedioic acid di-N-hydroxysuccinimidyl ester
(K100 MALDI MS analysis kit) were obtained from
CovalX AG (Zurich, Switzerland). These cross-linkers
are optimized for reacting in water or PBS buffer at pH
7–9. Sinapinic acid (SA) also came with the CovalX
analysis kit. Single stranded DNA C3, A9, and C9 were
purchased from Microsynth AG (Balgach, Switzerland).
Sample Preparation
In all experiments, the ligand RA was always present in
solution with the receptors. Before nanoESI MS mea-
surements, the RAR, RAR·RXR, and DR5 stock solu-
tions were desalted and buffer exchanged against 50
mM NH4OAc (pH 7.4), using Micro Bio-Spin 6 columns
(Bio-Rad, Reinach, Switzerland). DR5 was incubated
with RAR for 15 min at room temperature before
measurement. Relatively high concentrations (15–20
M) of each protein and DNA were used to obtain good
spectra.
The RAR and the RAR·RXR stock solutions were
diluted to 5.5 M and 5 M, respectively, before
MALDI measurements. In the case of DR5 as well as
non-specific A9 and C9, a 5 M solution was incubated
with the proteins 15 min before adding the cross-linker.
The cross-linking reactions were carried out using a
solution containing the abovementioned cocktail of
cross-linkers specific for amino groups (K100). The
protein complexes, with or without DNA, were stabi-
lized with the cross-linking mixture at about 50-fold
molar excess, freshly made, in a total volume of 10 L.
The sample and the cross-linker were incubated for 120
min at room temperature to allow the reaction to
go to completion. As RA ligand is light sensitive, tubes
were covered with aluminium foil during incubation.
After cross-linking, 1 L of the sample containing the
protein complex was directly mixed with 1 L of matrix
solution. The freshly made matrix solution contained
SA (10 mg/mL) in acetonitrile:water (1:1, vol/vol)
acidified with 0.1% (vol/vol) trifluoroacetic acid (TFA).
After mixing, 1 L of the sample was deposited on the
sample plate for MALDI MS analysis.
Mass Spectrometry
ESI mass spectra were acquired on a quadrupole time-
of-flight mass spectrometer (Q-TOF ULTIMA; Waters,
Manchester, UK) equipped with an automated chip-
based nanoESI system (Nanomate 100, Advion Bio-
sciences, Ithaca, NY, USA). To prevent dissociation of
ligand-bound RAR, the source pressure of the mass
spectrometer was raised to 3 mbar with a Speedivalve
(BOC Edwards, La Chaux-de-Fonds, Switzerland). Un-
der the conditions of high-pressure, the ion collisions
with the residual gas are less energetic, thus leaving the
noncovalent complexes intact. The transfer voltages of
the mass spectrometer were tuned so as to preserve the
noncovalent complexes during their transfer from the
solution phase to the mass spectrometer vacuum, as
previously described [38]. Best spectra obtained using
optimum conditions are shown here; however these
conditions were not the same for each case. Standard
Q-TOF instruments have a quadrupole with limited ion
transmission [39]. Using our Q-TOF instrument, it is
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possible to work up to m/z 7000 with optimization of
parameters and if one is willing to tolerate poor reso-
lution. In principle, quadrupoles on these instruments
can be upgraded for optimal transmission of ions up to
m/z 32,000 [40], but unfortunately this technology was
not available in our lab.
MALDI mass spectra were acquired on a time-of-
flight mass spectrometer (Reflex IV; Bruker Daltonics
GmbH, Bremen, Germany) equipped with a high-mass
detection system (HM1; CovalX AG, Zurich, Switzer-
land), which is a modified, commercial version of a
design previously described by Hillenkamp and co-
workers [16, 41]. The high-mass detection system pro-
vides high sensitivity with low saturation in the high
mass range up to 1 MDa. Typical accelerating volt-
ages were 20 kV; the gain voltage on the detector was
set to 2.8 kV, and the delayed extraction time was
automatically adapted by the instrument’s software
according to the selected mass range. Spectra were
averaged over 300 laser shots at different locations of
the sample.
Data Processing
Before data processing, each MALDI and nanoESI mass
spectrum was background-subtracted and smoothed with
Complex Tracker 1.1 (CovalX AG) or the MassLynx 4.0
software (Waters), respectively. Complex Tracker per-
mits to overlay control and cross-linked spectra and
also to subtract them to clearly detect the peaks corre-
sponding to the complexes formed.
Results and Discussion
Mass Spectrometric Detection of RAR·RXR and
RAR·RXR·DNA Complexes
The two receptors, RAR and RXR, were incubated with
9-cis RA ligand as described in the experimental part.
The mixture of ligand-bound RAR, RXR and DR5 was
analyzed with nanoESI MS. The nanoESI mass spec-
trum shows a major ion distribution between m/z 4700
and 6000, corresponding to a molecular weight of 94.77
kDa (Figure 2), in agreement with the theoretical mo-
lecular weight of a 2RA·RAR·RXR·dsDNA complex
(MW  94,558). The mass difference is due to some
unspecific clustering with solvent/buffer molecules, a
fact that also leads to peak broadening. Harsher condi-
tions did not allow the detection of the complex any-
more; it was not possible to obtain sharper peaks. The
ion distribution corresponding to the free nuclear re-
ceptor RXR (37,390 Da) can also be observed in the
spectrum. The peaks between m/z 3500 and 4500 are
attributed to RXR, RAR, and parts of the 2RA·RAR·
RXR·dsDNA complex charge state distribution but, for
simplicity, are not labeled in the spectrum. The pres-
ence of some free RXR and RAR suggests that the
complex is in equilibrium with its components in solu-
tion. Some dissociation may also result from the ioniza-
tion process or from dissociation in the gas phase. The
sample analyzed here already contained all components
(RAR, RXR, RA, and DR5). The individual components
were analyzed but not detected by nanoESI due to the
high salt content and low protein concentration of the
samples, especially in the case of RXR. Desalting was
attempted, but did not permit the observation of the
compounds.
The formation of the RAR·RXR heterodimer with
and without the DNA was also followed by MALDI
MS. A spectrum of a mixture of RAR and RXR, in the
presence of RA, before cross-linking is shown in Figure
3a. Peaks corresponding to RXR (37.0kDa) and RAR
(44.5kDa) are detected, as well as minor peaks of the
doubly charged species of each protein. In the presence
of RA, RAR and RXR were then incubated with the
K100 cross-linking kit. Following cross-linking, high-
mass MALDI shows a major signal of the RAR·RXR
heterodimer at 84.8 kDa, corresponding to the sum of
the combined masses of both receptors (Figure 3b). Both
RXR and RAR were also still detected, at 38.3 kDa and
46.4 kDa, respectively, as well as the doubly charged
complex at 42.4 kDa. The observed masses of the
proteins and complexes increase by 2%–5% due to the
presence of covalently bound cross-linkers. The pres-
ence of the free nuclear receptors “decorated” with
multiple cross-linker molecules could be a result of an
incomplete dimerization. It is also known that the
cross-linking process does not always go to completion,
thus the presence of free proteins is not surprising. The
ligand is not specified on the drawing in the figure,
because the MALDI ionization process may destroy the
binding between RA and the proteins, which is not
stabilized by the cross-linking process due to the struc-
Figure 2. Normalized nanoESI mass spectra of RAR·RXR·dsDR5
in 50 mM NH4OAc (pH 7.4). [Filled circle] Represents the
RA·RAR·RXR·DR5 complex, in good agreement with the theoret-
ical mass (94,558 Da). [Open square] Represents the free RXR left.
The grey diamond represents the RAR·RXR·2RA complex and the
white stars represent some impurities.
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Figure 3. High-mass MALDI mass spectra of the mixture RAR·RXR in the presence of RA.
(a) Control spectrum of RAR and RXR proteins without cross-linking. The peaks of the RAR
homodimer, the RXR homodimer, and the RAR·RXR heterodimer are observed at a much lower
intensity and can be attributed to non-specific dimers, probably induced by clustering, which can
occur in the MALDI plume [48, 49]. These gas-phase clusters are distinguishable from specific
noncovalent complexes by an exponential intensity decrease and are mainly dependent on the analyte
concentration and laser power [50, 51]. Lowering the concentration of the analyte or the laser power
easily eliminated these unspecific dimers (data not shown). (b) Detection of the RAR·RXR complex
after cross-linking. (c) After incubation with DR5, the RAR·RXR complex binds ssDR5 and dsDR5.
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ture of RA. The two receptors were then incubated with
DR5 and again submitted to the cross-linking proce-
dure. In Figure 3c, almost all the peaks observed are the
same as the ones seen when no DNA is added (Figure
3b). Singly charged RAR and RXR as well as RAR·RXR
heterodimer, singly and doubly charged, are detected.
One additional peak appears at 90.9 kDa, correspond-
ing to the mass of the heterodimer plus a single strand
of DR5. In addition, a shoulder at 97.8 kDa also appears,
which is attributed to the protein complex bound to the
double stranded DR5. These peaks are not present in
the control spectrum of the mixture of RA, RAR, RXR
and DNA, which was taken before cross-linking (data
not shown). As a further control, RAR and RXR, in the
presence of RA, were also incubated with DNA sam-
ples such as A9 and C9, which do not contain the
specific sequence recognized by the protein complex
(AGGTCA). This enabled us to test the specificity of
the complex: in all cases, spectra after cross-linking
only show the peak corresponding to the proteins or
specific protein complex; binding to A9 or C9 was
never observed.
The most probable representation of the mode of
interaction between the heterodimer and the DNA is
the one shown in Figure 3c. This drawing is based on
the known crystal structure of the RAR·RXR·dsDR1
complex and symbolizes the ligand binding domain
(large protein lobes) linked to the DNA binding domain
(smaller lobes) [11]. It is, however, known that the
heterodimer interacts with the DNA as a double strand
and not as a single strand. The fact that the peaks
corresponding to the RAR·RXR heterodimer plus ssDR5
and dsDR5 are quite weak is most probably due to the
low efficiency of the cross-linking reaction with DNA.
A further hypothesis to explain the higher abundance of
the RAR·RXR·ssDR5 species in the MALDI spectrum
would be that during the ionization process, the laser
breaks the hydrogen bonds between the two DNA
strands complexed to the heterodimer. Possibly the
cross-linking produces different species, some with
only one strand covalently bound to the protein and
others where both strands are covalently bound to the
complex. The MALDI ionization process may in the
former case disrupt the DNA double strand. Even with
multiple hydrogen bonds present in the structure of a
dsDNA, special conditions are required to study duplexes
with MALDI MS. In the case of protein-DNA, sample
conditions (acidic matrix) and laser can be at the origin of
the disruption of the dsDNA. Moreover, one study on
dsDNA 16-mers reported that to observe the double
stranded form by MALDI MS, DNA should have a GC
content of more than 75% [42]. DR5 contains only 50% of
GC in the sequence, which should thus not allow the
observation of the duplex. Moreover, MALDI spectra of
the dsDR5 alone showed the peak of the single strand to
be by far the most abundant species; the dsDR5 was
present with much lower intensity (data not shown).
With MALDI MS, the heterodimer and its complexes
with ssDR5 and with dsDR5 were detected. In the
known crystal structure of the complex consisting of
RAR, RXR, and DR1, the receptors interact together
while interacting with the DNA [11]. The spatial ar-
rangement in the RAR·RXR·dsDR5 complex is probably
quite similar. An observation is that the cross-linking
reaction seems to work even in the case of protein-DNA
binding, although with lower efficiency compared with
the case of protein–protein interactions.
Both nanoESI and MALDI data thus confirm the
binding of the heterodimer RAR·RXR with dsDR5. The
nanoESI data reflect the solution composition better,
i.e., the amount of heterodimer bound to the dsDR5.
Very similar information on the interaction can be
obtained using cross-linking combined with high-mass
MALDI MS.
Mass Spectrometric Characterization of RAR and
Effect of DR5 on RAR Dimerization
Under denaturing conditions, a broad distribution of
charge states (17 to 57) that can be assigned to ions
of the unfolded RAR monomer was observed by
nanoESI (data not shown). Using nondenaturing condi-
tions, the resulting nanoESI spectrum shows three
charge state distributions (m/z ranges 1000–1600, 1600–
2250, and 2250–3750), which were assigned to the RAR
monomer (data not shown). The deconvoluted molecu-
lar weight of 44.59 kDa measured with nanoESI agreed
well with the RAR molecular weight based on the
known amino acid sequence (MW  44,589 Da). The
distinct charge state distributions measured under near-
native conditions suggest the coexistence of different
RAR conformations in solution. The lowest charge of
RAR ions (m/z range 2250–3750, z  12, . . . , 16) is
thought to correspond to the most folded RAR confor-
mation (Figure 4a). We then incubated RA and RAR
with dsDR5, which contained the specific binding se-
quence against RAR in a 1:1 ratio. The nanoESI mass
spectrum shows a new ion distribution corresponding
to a deconvoluted molecular mass of 57.44 kDa (Figure
4b). Compared with the nanoESI mass spectrum of RAR
(Figure 4a), this is an increase of 12.85 kDa, in excellent
agreement with the molecular weight of the dsDR5
measured with nanoESI under nondenaturing condi-
tions (MW  12.85 kDa, data not shown). The same
experiment was performed with an excess of DR5, but
in that case, it was only possible to detect the DNA. The
conditions used here, optimized to detect the protein-
DNA complex, do not reveal the presence of the RA
ligand, which probably dissociates in the gas-phase. No
homodimer bound to dsDNA was detected with
nanoESI, because the expected high m/z of this (101.76
kDa) complex likely is beyond the accessible mass
range of our Q-TOF instrument (cf experimental part).
Detection of the heterodimer RAR·RXR bound to the
dsDNA was possible (cf. Figure 2) albeit likely close to
the transmission limits of the instrument. Since the
homodimer bound to the DNA is about 7 kDa heavier,
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it is probably just enough to prevent its detection. It
would be very interesting to repeat these experiments
using a Q-TOF instrument optimized for high m/z
transmission [40]. Using the exact same conditions as in
Figure 2, mainly the dsDR5 signal was observed (data
not shown). It was necessary to adapt the ionization and
detection conditions for each case, RAR  RXR versus
RAR alone, to detect complexes. This is the reason for
the broadened peaks in the heterodimer case (Figure 2)
compared with the RAR monomer (Figure 4).
After cross-linking and in the presence of RA, high-
mass MALDI showed essentially RAR monomer (Fig-
ure 5a). The peak corresponding to the doubly charged
RAR is also present. A small amount of homodimer
ions was detected, which can again be attributed to the
formation of non-specific RAR clusters during the
MALDI ionization process. A control spectrum of RAR
without cross-linker shows the same peak with similar
intensity (data not shown). After incubating the recep-
tor RAR with RA, an excess of DR5 and with the
cross-linkers, high-mass MALDI MS shows a substan-
tial increase of the homodimer intensity at 95.1 kDa
(Figure 5B). The measured increase in homodimer
abundance suggests a DR5 regulation of the RAR
dimerization in solution. Another species is detected, at
m/z 53,700, compatible with a monomer plus a single
strand of DR5. Two additional peaks were observed
next to the RAR homodimer signal after incubation
Figure 4. NanoESI mass spectra of RAR with and without DR5, in the presence of RA. Normalized
nanoESI mass spectra of (a) RAR in 50 mM NH4OAc (pH 7.4) and (b) RAR incubated with DR5 in 50
mM NH4OAc (pH 7.4). Once incubated with DR5, the molecular mass of RAR increased of 12,855 Da,
in excellent agreement with the measured molecular weight of the ds DR5.
641J Am Soc Mass Spectrom 2010, 21, 635–645 NUCLEAR HORMONE RECEPTOR–DNA COMPLEXES
with DR5, at 102.3 and 108.7 kDa, corresponding to an
increase of 7.2 and 13.6 kDa relative to the apo-RAR
homodimer (Figure 5b). Considering the low mass
accuracy of our MALDI instrument in this mass range
and the expected “decoration” due to the cross-linkers,
these mass differences are in reasonably good agree-
ment with the molecular weights of the ssDR5 (ssDR5,
MW  6299 and 6553 Da) and dsDR5 (MW  12,852
Da). We therefore assign the additional MALDI ion
peaks on the RAR homodimer to the bound ssDR5 and
dsDR5. The detection by MALDI MS of these two
protein–DNA complexes stabilized by cross-linkers
supports the notion that the DNA may show some
reactivity with the cross-linker. This was investigated
separately (see below). Due to the structure of RAR in
the RAR·RXR heterodimer complexed with its DNA,
the homodimer RAR may interact with DR5 in an
analogous fashion as described in the model of Rastine-
jad et al. [11] The peak at m/z 108700 most probably
represents the homodimer plus dsDR5 (drawing in
Figure 5b). The higher abundance of the peak corre-
sponding to the homodimer plus single stranded DR5,
m/z 102300, could be due to partial reaction of the DNA
with cross-linker attached on one end to the protein,
combined with a disruption of the dsDNA during the
ionization process, in analogy to the RAR·RXR case. To
verify the binding specificity between DR5 and RAR,
the receptor was incubated under similar conditions
with single stranded control DNA (i.e., A9 or C9, see
Experimental section). No increase in the abundance of
Figure 5. High-mass MALDI mass spectra of RAR without and with DR5, in the presence of RA.
Normalized MALDI spectra of RAR (a) after cross-linking stabilization and (b) after cross-linking and
incubation with DR5.
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the homodimer was detected. Furthermore, no com-
plexes were detected (data not shown). The increase of
dimer abundance once incubated with DR5 therefore
suggests that the homodimerization is induced by the
presence of the DNA.
The different intensities for the protein–DNA com-
plexes observed when comparing the RAR·RXR het-
erodimer and the RAR homodimer can be explained by
differences in the sequence of the proteins and in the
cross-linking efficiency. The cross-linker reacts prefer-
entially with free amino groups, e.g., side chains of the
lysines. Therefore the stabilization should occur more
effectively when lysines are abundant on the exterior of
a protein. Figure 6 shows the sequence of RAR and
RXR, with the DNA binding domain (in black) and the
ligand-binding domain (in grey italics). There are more
lysines in the sequence of RAR, especially in the DNA
binding domain, six compared with only one in the case
of RXR (Figure 6). Even in the vicinity of the DNA
binding domain (in black in Figure 6), the total number
of lysines is a bit larger, 15 for RAR compared with 13
for RXR (in bold). This may provide one explanation for
the lower intensity of the RAR·RXR·dsDR5 complex
peak compared with the RAR2·dsDR5 complex. To
investigate a possible ligation of protein and DNA, we
studied the reactivity of nucleic acids with NHS esters/
cross-linkers in more detail. Incubation of several dif-
ferent single-stranded DNAs with disuccinimidyl sub-
erate (DSS) did not show any reactivity of the DNA. A
water-soluble NHS ester containing sulfonate groups,
bis(sulfosuccinimidyl) suberate (BS3) was also tested.
(BS3) did show some reactivity with DNA, albeit an
unusual one. Judging from the appearance of a new
peak in the MALDI mass spectrum a species that
probably resulted from the attack of the sulfonate group
on the phosphate of the backbone was created. How-
ever, with DSS, which is representative of the compo-
nents of the K100 crosslinker “cocktail” used here, the
DNA clearly showed no reactivity at all.
An alternative explanation for the detection of the
protein-DNA complexes by MALDI MS is thus simply
ionic interactions between positively charged amino
acid residues and the phosphate backbone of DNA.
These types of ionic interactions are stable in the
gas-phase, and even stronger than in solution [43].
Some studies already described the detection of nonco-
valent complexes of ss or dsDNA with peptides by
MALDI MS [44–47]. This hypothesis is also in line with
the fact that RAR contains more K, R, and H (23 in total
in or around the DNA binding domain, K in bold, and
R as well as H underlined in Figure 6) than RXR (15 in
total). Lysines and arginines are positively charged at
the conditions used for the experiments as well as in the
gas-phase. Ionic interactions are thus a likely explana-
tion for the detection of the complexes between the
nuclear receptors and DR5 by MALDI MS. We believe
that chemical cross-linking enhanced by cooperative
effects from the high “local concentration” of cross-
linker that has already reacted with amino groups on
the protein surface is unlikely.
The different information obtained from the two MS
methods originate from the methods themselves. The
m/z limitation of our Q-TOF mass spectrometer (i.e., m/z
7000) does not allow the measurement of the native
RAR2·dsDR5 (MW  102 kDa). Using native condi-
tions, folded proteins typically generate fairly low
charge states that appear in the high mass m/z range,
often beyond the limit of the instrumentation. In the
case of MALDI MS, the complexes can be destroyed
during the ionization process. The monomer with one
Figure 6. Sequences of RAR and RXR. The DNA binding domain is in black, while the ligand binding
domain is in italics. Lysines are highlighted in bold, and arginines as well as histidines, potential
positively charged residues, are underlined.
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single strand of DNA bound that appears in the
MALDI spectra (Figures 3c and 5b) is likely due to
dissociation of a single DNA strand from the com-
plex, induced by the MALDI process.
Conclusions
Two complementary mass spectrometric methods were
used here to study nuclear receptor protein–DNA com-
plexes. RAR and RXR, in the form of homo- or het-
erodimers, complexed with DNA were characterized by
chemical cross-linking and high-mass MALDI MS as
well as by nondenaturing nanoESI MS. In the case of the
RAR·RXR heterodimer, nanoESI as well as high-mass
MALDI MS showed the complex between RAR·RXR
and the dsDR5, although with lower intensity for the
latter method. According to the high-mass MALDI MS
data, RAR forms a homodimer in solution only when
incubated with an excess of DR5. Both ionization meth-
ods confirm that dsDR5 interacts with RAR, which
shows that complex formation between RAR and the
direct repeat motive of the DNA does not require the
presence of RXR. The data obtained on these RAR-
RXR/DNA and RAR-RAR/DNA complexes will be
helpful for the elucidation of the structure–function
relationships of nuclear receptors and for the develop-
ment of efficient therapies in RAR-mediated diseases.
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